New Trappsol Cyclo Safety and Efficacy Data Available for NPC1
source: pixabay.com

New Trappsol Cyclo Safety and Efficacy Data Available for NPC1

On July 30, 2021, biopharmaceutical company Cyclo Therapeutics shared that it had released new and promising data regarding the safety, efficacy, and tolerability of Trappsol® Cyclo™ ("Trappsol Cyclo") for patients with…

Continue Reading New Trappsol Cyclo Safety and Efficacy Data Available for NPC1
New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
source: pixabay.com

New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

  In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…

Continue Reading New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease